Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DULOXETINE Cause Electrocardiogram repolarisation abnormality? 12 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Electrocardiogram repolarisation abnormality have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.0% of all adverse event reports for DULOXETINE.

12
Reports of Electrocardiogram repolarisation abnormality with DULOXETINE
0.0%
of all DULOXETINE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Electrocardiogram repolarisation abnormality From DULOXETINE?

Of the 12 reports, 2 (16.7%) required hospitalization, and 10 (83.3%) were considered life-threatening.

Is Electrocardiogram repolarisation abnormality Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does DULOXETINE Cause?

Nausea (7,355) Dizziness (6,983) Drug withdrawal syndrome (6,503) Headache (5,541) Fatigue (5,309) Insomnia (5,270) Anxiety (4,973) Paraesthesia (4,854) Drug ineffective (4,829) Hyperhidrosis (4,101)

What Other Drugs Cause Electrocardiogram repolarisation abnormality?

CLOZAPINE (25) QUETIAPINE (23) SERTRALINE (20) ALCOHOL (17) DIGOXIN (17) PROPOFOL (16) RIBOCICLIB (16) ALPRAZOLAM (15) ARIPIPRAZOLE (15) LEVETIRACETAM (15)

Which DULOXETINE Alternatives Have Lower Electrocardiogram repolarisation abnormality Risk?

DULOXETINE vs DUPILUMAB DULOXETINE vs DURAGESIC DULOXETINE vs DUROGESIC DULOXETINE vs DUROTEP MT DULOXETINE vs DURVALUMAB

Related Pages

DULOXETINE Full Profile All Electrocardiogram repolarisation abnormality Reports All Drugs Causing Electrocardiogram repolarisation abnormality DULOXETINE Demographics